NRX Pharmaceuticals CFO Ira Strassberg receives $1.3M in 2022
NRX Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: November 22, 2023
NRX Pharmaceuticals reported fiscal year 2022 executive compensation information on November 22, 2023.
In 2022, seven executives at NRX Pharmaceuticals received on average a compensation package of $688K, a 58% decrease compared to previous year.
Average pay of disclosed executives at NRX Pharmaceuticals
Ira Strassberg, Chief Financial Officer, received $1.3M in total. 76% of Strassberg's compensation, or $1M, was in option awards. Strassberg also received $308K in salary.
Jonathan Javitt, Chief Executive Officer, received a compensation package of $874K, which increased by 132% compared to previous year. 99% of the compensation package, or $867K, was in salary.
Stephen H. Willard, Chief Executive Officer, earned $800K in 2022.
Robert Besthof, Chief Executive Officer, received $651K in 2022, which increases by 147% compared to 2021.
Alessandra Daigneault, General Counsel, earned $585K in 2022, a 74% decrease compared to previous year.
Seth Van Voorhees, Chief Financial Officer, received $355K in 2022.
Riccardo Panicucci, CMC and Technical Operations Advisor, earned $240K in 2022.
Related executives
Stephen Willard
NRX Pharmaceuticals
Chief Executive Officer
Jonathan Javitt
NRX Pharmaceuticals
Chairman
Robert Besthof
NRX Pharmaceuticals
Chief Executive Officer
Seth Van Voorhees
NRX Pharmaceuticals
Chief Financial Officer
Riccardo Panicucci
NRX Pharmaceuticals
CMC and Technical Operations Advisor
Ira Strassberg
NRX Pharmaceuticals
Chief Financial Officer
Alessandra Daigneault
NRX Pharmaceuticals
General Counsel
You may also like
Source: SEC filing on November 22, 2023.